Skip to main content
ROVI Subsidiaries
Spain
Germany
France
Italy
Poland
Portugal
United Kingdom
Language
Spanish
Spanish
English
English
English
Español
Home
ROVI
History
Group structure
Business units
International expansion
Strategy
Licenses
Contact
Products
Prescription Pharmaceuticals
Hospital Products
Manufacturing
CDMO
Own product Manufacturing
R&D
Shareholders and Investors
The share
Investor's Calendar
News
Financial and Business Information
CMNV Communications
ESG
Corporate Governance
Telematic assistance access
Prior Registration On-Line Attendance
On-Line Attendance
Sustainability
Responsible governance
Commitment to people
Environmental Commitment
Ethics Channel
Media
FAQS
News
ROVI up to date
Contact
Work with Us
TELEMATIC ASSISTANCE ACCESS
Home
Contact
News
News
Find out more …
FAQs
News
ROVI up to date
Contact
Filter results
Year
Year
-Year
2025
2024
2023
2022
2021
2020
2019
From
Date
E.g., 09/03/2025
To
Date
E.g., 09/03/2025
25/02/2025
2024 results press release
ROVI ACHIEVED REVENUE OF 764.6 MILLION EUROS AND INCREASED ITS GROSS MARGIN BY 3.7 PERCENTAGE POINTS
Download
